Antibiotic sequential therapy for febrile neutropenia in pediatric patients with malignancy

Pediatric Hematology and Oncology

Volumn 17, Issue 1, 2000, Pages 93-98

  Bernig, Toralf ^a   Weigel, Steffen ^a   Mukodzi, Sally ^a   Reddemann, Hans ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Antibiotic sequence therapy; Neutropenic fever; Pediatric malignant disease

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CILASTATIN PLUS IMIPENEM; FLUCONAZOLE; GENTAMICIN; IMIPENEM; PIPERACILLIN; TEICOPLANIN; TOBRAMYCIN;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW DEPRESSION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; INFANT; LEUKOCYTE COUNT; MALE; MALIGNANT NEOPLASTIC DISEASE; PROTEIN BLOOD LEVEL; RECTUM TEMPERATURE;

EID: 0033957822     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/088800100276703     Document Type: Article

References (17)

1. EORTC International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada - Clinical Trial Group. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic patients. J Infect Dis. 1991;163:951-958.
2. EORTC International Antimicrobial Therapy Cooperative Group. Efficacy and toxicity of single daily doses of amikacin and ceftriaxon versus multiple doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. Ann Intern Med. 1993;119:584-593.
3. Kern W, Kurrie E, Schmeiser T. Streptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy: a review of 55 cases. Infection. 1990;18:138-145.
4. Kiehn TE, Armstrong D. Changes in the spectrum of organisms causing bacteremia and fungemia in immunocompromised patients due to venous acces devices. Eur J Clin Microbiol Infect Dis. 1990;9:869-872.
5. Boogaerts MA. Anti-infective strategies in neutropenia. J Antimicrob Chemother. 1995;36(Suppl A):167-178.
6. Glauser M, Boogaerts M, Cordonnier C, Palmblad J, Martino P. Empiric therapy of bacterial infections in severe neutropenia. Clin Microbiol Infect. 1997;3 (Suppl 1):77-86.
7. Hughes WT, Armstrong D, Bodey GP, et al. 1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever: guidelines from the infectious diseases society of america. Clin Infect Dis. 1997;25:551-573.
8. Bochud PY, Calandra T, Francioli P. Bacteremia due to viridans streptococci in neutropenic patients: a review. Am J Med. 1994;97:256-264.
9. Sotiropoulus SV, Jackson MA, Woods JM. Alpha-streptococcal septicemia in leukemic children treated with continuous or large dosage intermittent cytosine arabinoside. Pediatr Infect Dis. 1989;8:755-758.
10. Weismann SJ, Scoopo FJ, Johnson GM. Septicemia in pediatric oncology patients: the significance of viridans streptococcal infections. J Clin Oncol. 1990;8:453-459.
11. Chow AW, Jewesson PJ, Kureishi A, Phillips GL. Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients. Eur J Haematol. 1993;51 (Suppl 54):18-24.
12. Lemerle S, de La Rocque F, Lamy R, Fremaux A, Bernaudin F, Lobut JB, Reinert P. Teicoplanin in combination therapy for febrile episodes in neutropenic and non-neutropenic paediatric patients. J Antimicrob Chemother. 1988;21 (Suppl A):113-116.
13. Cometta A, Glauser MP. Empiric antibiotic monotherapy with carbapenems in febrile neutropenia: a review. J Chemother. 1996;8:375-381.
14. Freifeld AG. Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem. J Clin Oncol. 1995;13:165-173.
15. Klastersky J, Vamecq G, Cappel R, Swings G, Vandenborre L. Effects of the combination of gentamicin and carbenicillin on the bactericidal activity of serum. J Infect Dis. 1972;125:183-186.
16. Katz JA, Mustafa MM, Bash RO, Cash JV, Buchanan GR. Value of c-reactive protein determination in the initial diagnostic evaluation of the febrile, neutropenic child with cancer. Pediatr Infect Dis J. 1992;11:708-712.
17. Ligtenberg PC, Hoepelman IM, Oude-Sogotoen GA, et al. C-reactive protein in the diagnosis and management of infections in granulocytopenic and non-granulocytopenic patients. Eur J Clin Microbiol Infect Dis. 1991;10:25-31.